[{"data":1,"prerenderedAt":321},["ShallowReactive",2],{"story-174064-en":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":57,"questions":58,"relatedArticles":80,"body_color":319,"card_color":320},"174064",null,"Pharma M&A Consolidation Reshapes Women's Health Supply Chain | Cross-Border Seller Opportunities","- $11.75B Sun Pharma-Organon deal signals major supply chain restructuring affecting 140+ countries; creates opportunities for logistics, packaging, and health product sellers in emerging markets",[],[10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,19,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56],"https://cdn.zonebourse.com/static/resize/1200/675//images/reuters/2025-03-13T172638Z_1_LYNXMPEL2C0VY_RTROPTP_3_BUSINESS-FRANCE.JPG","https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iqZb5h6mI.cY/v1/1200x572.jpg","https://endpoints.news/wp-content/uploads/2024/02/organon-shutterstock-tile.jpg","https://resize.indiatvnews.com/en/resize/newbucket/1200_-/2026/04/sunpharmashareprice-1777263657.webp","https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iNDQUyNp6mpE/v0/1200x797.jpg","https://etimg.etb2bimg.com/thumb/msid-130542392,width-1200,height-900,resizemode-4/.jpg","https://im.rediff.com/1200-900/money/2015/jun/18sun.jpg","https://akm-img-a-in.tosshub.com/businesstoday/images/video/202604/thumbnail-original_2044.jpg?size=1280:720","https://media.assettype.com/freepressjournal/2026-04-27/zh4k9vjs/Sun-Pharma-1.jpg","https://images.moneycontrol.com/static-mcnews/2025/11/20251105154649_sunpharmartr.png?impolicy=website&width=1600&height=900","https://cdn.thepharmaletter.com/files/2024/06/e1b4ceb0-21cd-11ef-ad1f-e33a28dd5e74-merger_acquisition_deal_shutterstock_large.png","https://images.financialexpressdigital.com/2026/04/Sunpharma.jpg","https://images.cnbctv18.com/uploads/2026/04/1777264603_9W6zcNqB3a-bondmarketsMar04jpg-W7dnecBiOs.jpg?impolicy=website&width=1200&height=900","https://www.devdiscourse.com/img?imageUrl=https://devdiscourse.blob.core.windows.net/aiimagegallery/29_05_2025_22_59_34_2199094.png&width=1280","https://news.stocktwits-cdn.com/large_Organon_jpg_c79aa47348.webp","https://images.moneycontrol.com/static-mcnews/2026/04/20260427025800_Opening-Bell_-27-April.jpg?impolicy=website&width=1600&height=900","https://bl-i.thgim.com/public/incoming/8g668a/article70898291.ece/alternates/LANDSCAPE_1200/iStock-1169106100.jpg","https://s.yimg.com/ny/api/res/1.2/fQyArhD9MvgVl1RwbZ2aqw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQyNw--/https://media.zenfs.com/en/insidermonkey.com/f9df7ad2038f323b3e9a830e7c3ccf43","https://bsmedia.business-standard.com/_media/bs/img/article/2025-10/31/full/1761903240-8152.JPG","https://imageio.forbes.com/specials-images/imageserve/69ef4ae7555e241d1632cf74/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds","https://media.licdn.com/dms/image/v2/D5612AQHTL7HOP3n6XQ/article-cover_image-shrink_720_1280/B56Z3Neq3_KsAI-/0/1777268863140?e=2147483647&v=beta&t=8HfQsqD63b9tphR7P9luewzQ_isUFmJtnUvv9tQUbIk","https://i.cdn.newsbytesapp.com/images/l11720260427101150.jpeg","https://images.wsj.net/im-41860589?width=700&height=441","https://images.barrons.com/im-82023389?width=700&height=466","https://images.whalesbook.com/images/thumbnail_69eecae65a43f6b807be990a_1536_864.jpeg","https://m.economictimes.com/thumb/msid-130549074,width-1200,height-900,resizemode-4,imgsize-157274/sun-pharmas-founder-dilip-shanghvi-is-eyeing-a-massive-12-5-billion-acquisition-of-us-based-organon-co-.jpg","https://images.indianexpress.com/2026/04/Sun-organon.jpg","https://media.assettype.com/dt-next/2026-04-27/k3oywwo7/AMP-New-Template-.png?w=640&mode=crop&ar=3:4","https://img.mathrubhumi.com/view/acePublic/alias/contentid/1qqigau8yob5112q5g4/0/bse-jpg.webp?f=1x1&w=1080&q=0.8","https://media.licdn.com/dms/image/v2/D5612AQEctRssWBlKBw/article-cover_image-shrink_720_1280/B56Z244cVOKwAM-/0/1776923297910?e=2147483647&v=beta&t=Bmac81L3sL-uDxkj6_DaQqrqTq7i27m4Mma3BC5wwYA","https://m.economictimes.com/thumb/msid-130535118,width-1200,height-900,resizemode-4,imgsize-47698/dilip-shanghvi.jpg","https://image.cnbcfm.com/api/v1/image/108297381-1777254027701-gettyimages-2183054876-vcg111528638910.jpeg?v=1777254039&w=1600&h=900","https://cdn.zonebourse.com/static/resize/1200/675//images/reuters/2019-12-11T174309Z_1_LYNXMPEFBA1L8_RTROPTP_3_BRITAIN-EU-MARKETS.JPG","https://etimg.etb2bimg.com/thumb/msid-130545384,imgsize-34428,width-1200,height=627,overlay-etlegal,resizemode-75/industry/azb-white-case-cam-sullivan-cromwell-act-on-organons-acquisition-by-sun-pharma-usa.jpg","https://imgproxy.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/19237236/ozxs4t/ALTERNATES/master-3_2/organon-m-a-sunpharma","https://media.assettype.com/barandbench%2F2026-04-27%2F7l7mapuy%2FChatGPT-Image-Apr-27-2026-112719-AM.png?rect=0%2C12%2C1536%2C864&w=1200&h=675&auto=format%2Ccompress&fit=crop","https://media.fortuneindia.com/fortune-india/import/2021-12/f7b2dfd4-e576-4018-8479-0895519a4861/dilip_pic.jpg?auto=format,compress&format=webp&w=1200&h=675&dpr=1.0&q=90&fit=cover","https://portfolio.investmentguruindia.com/uploads/news/pharma%20sector_988.jpg","https://images.whalesbook.com/images/thumbnail_69ef428b5a43f6b807c08008_1536_864.jpeg","https://static.toiimg.com/thumb/msid-130543821,width-1280,height-720,imgsize-1544328,resizemode-4,overlay-toi_sw,pt-32,y_pad-600/photo.jpg","https://www.reuters.com/resizer/v2/AK2JCLT5DBIZ5PQ4YVTXZQCWZM.jpg?auth=1d49963d7755467d09e96141cd0f55321e26fb7f6ff4e450a620c123fe859cb8&width=1080&quality=80","https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1346213103/image_1346213103.jpg?io=getty-c-w1280","https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1434365769/image_1434365769.jpg?io=getty-c-w1536","https://www.livemint.com/lm-img/img/2026/04/27/1600x900/logo/SUN-PHARM-RESULTS--0_1757255629292_1757255644553_1777274458902.JPG","https://invezz.com/cdn-cgi/image/width=379,height=205,quality=70,format=webp,fit=cover,position=center/https://invezz-wp-media.lon1.digitaloceanspaces.com/2026/04/Investor-looking-at-rising-stock-market-chart.png","https://akm-img-a-in.tosshub.com/indiatoday/images/story/202604/sun-pharma-organon-deal-is-the-largest-overseas-acquisition-by-an-indian-pharmaceutical-company-272523818-16x9.png?VersionId=yoJk6YuyT0UfSv9R2FqNJuDD1jbl6O5.?size=1280:720","https://images.moneycontrol.com/static-mcnews/2025/11/20251105114831_sunpharmartr1.png?impolicy=website&width=1600&height=900","The $11.75 billion acquisition of U.S.-based Organon by India's Sun Pharmaceutical Industries (announced April 26, 2026) represents one of the largest cross-border pharmaceutical M&A transactions, with significant implications for global supply chain partners and e-commerce sellers. Sun Pharma's all-cash deal at $14 per share positions the combined entity as a top-25 global pharmaceutical company with $12.4 billion in combined revenues, operating across 140 countries with 70+ products and six EU/emerging market manufacturing facilities.\n\n**Supply Chain Consolidation Impact**: This acquisition exemplifies broader pharmaceutical industry consolidation trends that directly affect cross-border sellers. Organon's established presence in the U.S., Europe, China, Canada, and Brazil—combined with Sun Pharma's emerging market strength—creates a restructured distribution network. For sellers in logistics, packaging, and healthcare product categories, this consolidation signals potential partnership opportunities with the merged entity's expanded operations. The deal's net debt-to-EBITDA improvement from 4x to 2.3x indicates financial stability for long-term supplier relationships, reducing counterparty risk for vendors.\n\n**Women's Health Category Expansion**: The acquisition elevates Sun Pharma's innovative medicine segment from 20% to 27% of total sales, with specific focus on dermatology, ophthalmology, and onco-dermatology. This portfolio strengthening creates downstream opportunities for sellers in complementary health and beauty categories on Amazon, eBay, and Shopify. Women's health products—including supplements, skincare, and wellness items—represent a rapidly growing e-commerce segment. Cross-border sellers can leverage this consolidation trend to identify emerging product gaps in women's health, particularly in markets where Organon's 70-product portfolio previously dominated (U.S., Europe, Brazil, Canada, China).\n\n**Regulatory and Operational Risks**: The deal requires regulatory approvals across multiple jurisdictions with no specified timeline, creating 6-12 month uncertainty. During integration, supply chain disruptions are common—Organon's manufacturing facilities across the EU and emerging markets may experience operational changes. Sellers relying on pharmaceutical supply chain logistics should monitor regulatory filing progress and prepare contingency plans for potential shipping delays or route changes. The $8.6 billion debt Organon carries may trigger cost-cutting measures affecting supplier terms, potentially increasing payment cycles from 30 to 45-60 days.\n\n**Market Consolidation Precedent**: This represents Sun Pharma's sixth major acquisition in 16 years (following 2007 Taro Pharma and 2014 Ranbaxy acquisitions), demonstrating Indian pharmaceutical companies' increasing capability to execute large-scale international deals. This pattern signals accelerating consolidation in the $1.4 trillion global pharmaceutical market, creating both opportunities and risks for sellers. Consolidation typically leads to supplier rationalization—fewer, larger vendors preferred—but also creates opportunities for specialized logistics providers and packaging suppliers who can scale with merged operations.",[59,62,65,68,71,74,77],{"title":60,"answer":61,"author":5,"avatar":5,"time":5},"What timeline should sellers expect for supply chain changes post-acquisition?","The deal was announced April 26, 2026, but no specific regulatory approval timeline was provided. Typically, pharmaceutical M&A requires 6-12 months for FDA, EMA, and other regulatory approvals across 140 countries. Integration planning usually begins immediately, with operational changes rolling out 3-6 months post-close. Sellers should expect: (1) immediate supplier communication from integration teams (months 1-2), (2) contract renegotiations (months 2-4), (3) operational transitions (months 3-9), and (4) full integration completion (months 9-12). Monitor SEC filings and press releases for regulatory progress updates.",{"title":63,"answer":64,"author":5,"avatar":5,"time":5},"Which geographic markets offer the most opportunity from this consolidation?","Organon operates across 140 countries with key markets in the U.S., Europe, China, Canada, and Brazil. The acquisition strengthens Sun Pharma's presence in developed markets (U.S., Europe) while leveraging its emerging market distribution network. Sellers should prioritize: (1) U.S. market—critical for regulatory approval and market access, (2) European Union—six manufacturing facilities create logistics opportunities, (3) Brazil and emerging markets—Sun Pharma's traditional strength, (4) China—high-growth women's health market. Cross-border sellers can target these regions with complementary health products, particularly women's health and dermatology categories where the merged entity will focus.",{"title":66,"answer":67,"author":5,"avatar":5,"time":5},"What are the financial risks for suppliers during this pharmaceutical M&A integration?","Organon carries $8.6 billion in debt, though the merged entity improves to a healthier 2.3x net debt-to-EBITDA ratio. Key risks include: (1) supplier rationalization—consolidated companies typically reduce vendor counts by 20-30%, (2) extended payment terms during integration, (3) potential cost-cutting measures affecting supplier margins, and (4) operational disruptions during the 6-12 month integration period. Sellers should diversify customer bases and avoid over-reliance on Organon or Sun Pharma contracts. Request payment guarantees and monitor the deal's regulatory approval progress through SEC filings and EMA notifications.",{"title":69,"answer":70,"author":5,"avatar":5,"time":5},"How does this deal reflect broader pharmaceutical industry consolidation patterns?","This represents Sun Pharma's sixth major acquisition in 16 years, demonstrating accelerating consolidation in the $1.4 trillion global pharmaceutical market. Indian pharmaceutical companies increasingly execute large-scale international acquisitions to access developed markets and achieve economies of scale. This pattern creates both opportunities and risks: larger consolidated players prefer fewer, larger suppliers (favoring established vendors), but also create opportunities for specialized logistics and packaging providers who can scale operations. Sellers should expect continued consolidation, making it critical to build relationships with merged entities' procurement teams early.",{"title":72,"answer":73,"author":5,"avatar":5,"time":5},"What immediate actions should healthcare product sellers take regarding this acquisition?","Immediate actions (0-30 days): (1) Review current supplier relationships with Organon or Sun Pharma; if applicable, request written confirmation of contract continuity post-close, (2) Monitor SEC EDGAR filings and press releases for regulatory approval updates, (3) Identify product gaps in women's health, dermatology, and ophthalmology categories on Amazon and eBay to capitalize on consolidation-driven market shifts. Strategic adjustments (1-6 months): (1) Develop contingency plans for potential supply chain disruptions during integration, (2) Consider expanding women's health product portfolio given the merged entity's strategic focus, (3) Build relationships with Sun Pharma's procurement team through industry events and LinkedIn outreach. Risk mitigation: Monitor payment terms closely and avoid over-reliance on single pharmaceutical supplier relationships.",{"title":75,"answer":76,"author":5,"avatar":5,"time":5},"How does the Sun Pharma-Organon acquisition affect cross-border sellers in healthcare logistics?","The $11.75 billion deal creates significant supply chain restructuring across 140 countries. Sellers in logistics, packaging, and healthcare distribution should expect 6-12 months of integration uncertainty as the merged entity consolidates operations. Organon's six EU and emerging market manufacturing facilities will likely undergo optimization, potentially creating new vendor opportunities for specialized logistics providers. However, suppliers should prepare for potential payment cycle extensions (30 to 45-60 days) due to Organon's $8.6 billion debt load. Monitor regulatory filing progress through FDA and EMA channels for timeline clarity.",{"title":78,"answer":79,"author":5,"avatar":5,"time":5},"What product categories benefit from this pharmaceutical consolidation trend?","Women's health products represent the primary opportunity, as Sun Pharma's innovative medicine segment grows from 20% to 27% post-acquisition. Complementary e-commerce categories include dermatology products, ophthalmology supplies, oncology-related wellness items, and women's health supplements. The acquisition signals strong market demand in these segments across the U.S., Europe, China, Canada, and Brazil. Sellers on Amazon, eBay, and Shopify can identify product gaps in women's health where Organon's 70-product portfolio previously dominated, particularly in emerging markets where Sun Pharma has stronger distribution.",[81,86,91,96,101,105,109,113,117,121,125,129,133,137,142,146,151,155,159,163,167,172,176,181,185,189,194,198,203,207,211,215,219,223,228,232,237,242,246,250,254,258,263,266,270,274,278,282,286,290,294,298,302,306,310,315],{"id":82,"title":83,"source":84,"logo":22,"time":85},810153,"Sun Pharma a trading play on dips, banks may face difficult June quarter: Dharmesh Kant","https://www.cnbctv18.com/videos/market/dharmesh-kant-chola-securities-sun-pharma-deal-banks-provisioning-outlook-indusind-axis-reliance-19893767.htm","8H AGO",{"id":87,"title":88,"source":89,"logo":44,"time":90},811121,"India's Sun Pharmaceutical acquires MSD spin-off for USD 11.75bn","https://medwatch.com/News/Pharma___Biotech/article19237640.ece","3H AGO",{"id":92,"title":93,"source":94,"logo":21,"time":95},810154,"Sun Pharma in global reckoning with daring Organon deal; all eyes now on debt & EBITDA","https://www.financialexpress.com/business/industry-sun-pharma-in-global-reckoning-with-daring-organon-deal-all-eyes-now-on-debt-amp-ebitda-4219246/","9H AGO",{"id":97,"title":98,"source":99,"logo":20,"time":100},811122,"Sun Pharma advances $13 billion Organon bid as Indian drugmakers eye their time in the sun","https://www.thepharmaletter.com/pharma-news/sun-pharma-advances-13-billion-organon-bid-as-indian-drugmakers-eye-their-time-in-the-sun","4H AGO",{"id":102,"title":103,"source":104,"logo":49,"time":95},810155,"Sun Pharma to acquire US-based Organon in $11.75 billion deal, among biggest overseas buys by Indian firm","https://timesofindia.indiatimes.com/business/india-business/sun-pharma-to-acquire-organon-in-11-75-billion-deal-among-biggest-overseas-buys-by-indian-firms/articleshow/130543624.cms",{"id":106,"title":107,"source":108,"logo":33,"time":100},811123,"Organon Stock Soars After Sun Seals Takeover. Why Pharma M&A Is a Hot Play.","https://www.barrons.com/articles/organon-stock-takeover-sun-parmaceutical-1f71698a",{"id":110,"title":111,"source":112,"logo":13,"time":95},810156,"Sun Pharma shares in action on acquisition update of US-based Organon & Co for $11.75 billion","https://www.indiatvnews.com/business/markets/sun-pharma-shares-price-acquisition-of-us-based-organon-for-usd-1-75-billion-2026-04-27-1039034",{"id":114,"title":115,"source":116,"logo":5,"time":100},811124,"Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's biggest pharma deal","https://www.rte.ie/news/business/2026/0427/1570378-indias-sun-pharma-to-buy-organon/",{"id":118,"title":119,"source":120,"logo":28,"time":95},810157,"Sun Pharma rallies 6%, top gainer among Sensex stocks; here's why","https://www.business-standard.com/markets/news/sun-pharma-rallies-6-top-gainer-among-sensex-stocks-here-s-why-126042700186_1.html",{"id":122,"title":123,"source":124,"logo":19,"time":100},811125,"From Ranbaxy to Organon: How Sun Pharma’s M&A strategy has evolved over 12 years","https://www.moneycontrol.com/news/business/from-ranbaxy-to-organon-how-sun-pharma-s-m-a-strategy-has-evolved-over-the-decade-13900573.html",{"id":126,"title":127,"source":128,"logo":5,"time":95},810158,"Sun Pharma Shares Jump After Organon Acquisition Deal; Top Gainer On Nifty 50","https://www.ndtvprofit.com/markets/sun-pharma-share-price-today-jump-after-organon-acquisition-deal-top-gainer-on-nifty-50-11413616",{"id":130,"title":131,"source":132,"logo":35,"time":100},811126,"Sun Pharma: How a small Kolkata trader became a global buyout artist","https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/dilip-shanghvi-sun-pharma-organon-12-5-billion-acquisition-strategy-global-expansion-how-a-small-kolkata-trader-became-a-global-buyout-artist/articleshow/130548787.cms",{"id":134,"title":135,"source":136,"logo":24,"time":95},810159,"OGN Stock Set For Blastoff? Sun Pharma Offers 24% Premium In All-Cash Buyout Deal","https://stocktwits.com/news-articles/markets/equity/ogn-stock-jumps-after-sun-pharma-all-cash-buyout-offer/cZBNaqaRe2f",{"id":138,"title":139,"source":140,"logo":43,"time":141},811127,"AZB, White & Case, CAM, Sullivan & Cromwell act on Organon’s acquisition by Sun Pharma USA","https://legal.economictimes.indiatimes.com/news/industry/azb-white-case-cam-sullivan-cromwell-act-on-organons-acquisition-by-sun-pharma-usa/130545384","7H AGO",{"id":143,"title":144,"source":145,"logo":30,"time":141},811128,"Reliance gets a fresh upside call; Sun Pharma’s $11.75B Organon deal; Centre's potential ₹5,000 crore credit relief for airlines & more","https://www.linkedin.com/posts/cnbc-tv18_reliance-gets-a-fresh-upside-call-sun-pharma-activity-7454405978961149952-5Kb_",{"id":147,"title":148,"source":149,"logo":27,"time":150},810270,"Organon (OGN) Takeover Bid Climbs to $13B, Shares Soar 30.9%","https://finance.yahoo.com/markets/stocks/articles/organon-ogn-takeover-bid-climbs-020017548.html","2D AGO",{"id":152,"title":153,"source":154,"logo":23,"time":85},810150,"Sun Pharma’s Strategic Acquisition and the Ongoing Opioid Crisis","https://www.devdiscourse.com/article/entertainment/3888038-sun-pharmas-strategic-acquisition-and-the-ongoing-opioid-crisis",{"id":156,"title":157,"source":158,"logo":36,"time":85},810151,"Sun Pharma to acquire Organon for $11.75 bn: How this will expand US footprint, why the timing is significant","https://indianexpress.com/article/explained/explained-economics/sun-pharma-organon-acquisition-11-75-bn-timing-significance-10657636/",{"id":160,"title":161,"source":162,"logo":31,"time":85},810152,"Sun Pharma seals India's biggest overseas acquisition in 20 years","https://www.newsbytesapp.com/news/business/sun-pharma-seals-12b-organon-deal-india-s-biggest-pharma-acquisition/story",{"id":164,"title":165,"source":166,"logo":46,"time":90},811120,"Sun Pharma’s Organon buy: The Indian pharma giant that grew through acquisitions over decades","https://www.fortuneindia.com/business-news/sun-pharmas-organon-buy-the-indian-pharma-giant-that-grew-through-acquisitions-over-decades/134463",{"id":168,"title":169,"source":170,"logo":42,"time":171},811118,"Organon to pay Sun Pharmaceutical $120 mln termination fee if deal terminated","https://www.marketscreener.com/news/organon-to-pay-sun-pharmaceutical-120-mln-termination-fee-if-deal-terminated-ce7f59dcde8dff2d","2H AGO",{"id":173,"title":174,"source":175,"logo":5,"time":90},811119,"Sun Pharma organon deal lifts Organon on $11.75B all-cash bid","https://en.cryptonomist.ch/2026/04/27/sun-pharma-organon-deal/",{"id":177,"title":178,"source":179,"logo":15,"time":180},810164,"Sun Pharma strikes $11.7 billion deal to acquire Organon","https://pharma.economictimes.indiatimes.com/news/mergers-and-acquisitions/sun-pharma-strikes-11-7-billion-deal-to-acquire-organon/130542392","10H AGO",{"id":182,"title":183,"source":184,"logo":34,"time":180},810165,"Sun Pharma's $11.75B Deal, Zydus Drug Mark India Pharma's Global Push","https://www.whalesbook.com/news/English/healthcarebiotech/Sun-Pharmas-dollar1175B-Deal-Zydus-Drug-Mark-India-Pharmas-Global-Push/69eecae65a43f6b807be990b",{"id":186,"title":187,"source":188,"logo":16,"time":180},810166,"Sun Pharma to Acquire Organon for $11.75 Billion","https://money.rediff.com/news/market/sun-pharma-to-acquire-organon-for-11-75-billion/45999720260427",{"id":190,"title":191,"source":192,"logo":19,"time":193},810167,"Sun Pharma seals Indian pharma's biggest-ever deal with $11.75 billion Organon buy","https://www.moneycontrol.com/news/business/sun-pharma-seals-indian-pharma-s-biggest-ever-deal-with-11-75-billion-organon-buy-13900066.html","11H AGO",{"id":195,"title":196,"source":197,"logo":26,"time":193},810168,"4 pharma stocks in focus: Sun Pharma, Zydus, Alembi, Rubicon","https://www.thehindubusinessline.com/markets/focus-on-these-4-pharma-stocks-sun-pharma-zydus-alembi-rubicon-on-monday/article70910599.ece",{"id":199,"title":200,"source":201,"logo":56,"time":202},810169,"Sun Pharma to acquire US-listed Organon in $12 billion deal","https://www.moneycontrol.com/news/business/sun-pharma-to-acquire-us-listed-organon-in-12-billion-deal-13900040.html","12H AGO",{"id":204,"title":205,"source":206,"logo":38,"time":95},810160,"Markets set for positive opening on global cues, Sun Pharma deal and India–New Zealand FTA","https://english.mathrubhumi.com/news/money/markets-set-for-positive-opening-on-global-cues-sun-pharma-deal-and-indianew-zealand-fta-y0zsb70k",{"id":208,"title":209,"source":210,"logo":5,"time":180},810161,"Sun Pharma to Host Investor Call on Organon Acquisition","https://www.tipranks.com/news/company-announcements/sun-pharma-to-host-investor-call-on-organon-acquisition",{"id":212,"title":213,"source":214,"logo":18,"time":180},810162,"Sun Pharma Targets $12.4 Billion Scale With Organon Acquisition To Expand Global Presence","https://www.indiaipo.in/news/detail/sun-pharma-targets-124-billion-scale-with-organon-acquisition-to-expand-global-presence",{"id":216,"title":217,"source":218,"logo":25,"time":180},810163,"Opening Bell Live | Brent Oil tops $ 107 on Hormuz Standoff | Sun Pharma acquires Organon for $11.8b","https://www.moneycontrol.com/news/videos/business/markets/opening-bell-live-brent-oil-tops-107-on-hormuz-standoff-sun-pharma-acquires-organon-for-11-8b-13900177.html",{"id":220,"title":221,"source":222,"logo":5,"time":202},810170,"India’s Sun Pharma to acquire US-listed Organon in $11.8 billion deal","https://www.investing.com/news/stock-market-news/indias-sun-pharma-to-acquire-uslisted-organon-in-118-billion-deal-4637513",{"id":224,"title":225,"source":226,"logo":5,"time":227},810171,"Sun Pharma signs Definitive Agreement to Acquire Organon","https://www.businesswire.com/news/home/20260426881370/en/Sun-Pharma-signs-Definitive-Agreement-to-Acquire-Organon","13H AGO",{"id":229,"title":230,"source":231,"logo":5,"time":227},810172,"$11.75B drug deal would put Sun Pharma in 150 countries","https://www.stocktitan.net/news/OGN/sun-pharma-signs-definitive-agreement-to-acquire-ryhh7n9hcmbm.html",{"id":233,"title":234,"source":235,"logo":40,"time":236},810173,"ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till date","https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-set-to-acquire-organon-for-12-5-bn-its-biggest-till-date/articleshow/130534538.cms","21H AGO",{"id":238,"title":239,"source":240,"logo":10,"time":241},810174,"Sun Pharmaceutical Industries Limited entered into a definitive agreement to acquire Organon & Co. for $3.8 billion.","https://www.marketscreener.com/news/sun-pharmaceutical-industries-limited-entered-into-a-definitive-agreement-to-acquire-organon-co-f-ce7f59dcda81f324","1D AGO",{"id":243,"title":244,"source":245,"logo":12,"time":141},810142,"Sun Pharma to buy Organon for $11.75B in major portfolio expansion","https://endpoints.news/sun-pharma-to-buy-organon-for-11-75b-in-major-portfolio-expansion/",{"id":247,"title":248,"source":249,"logo":45,"time":141},810143,"White & Case, AZB, Sullivan, Cyril Amarchand Mangaldas act on Sun Pharma's $11.75 billion acquisition of Organon","https://www.barandbench.com/dealstreet/white-case-azb-partners-sullivan-cromwell-cyril-amarchand-mangaldas-act-on-sun-pharmas-billion-dollar-acquisition-of-organon",{"id":251,"title":252,"source":253,"logo":54,"time":141},810144,"Morning brief: Asia mixed, oil jitters surge, Sun Pharma’s big bet","https://invezz.com/za/news/2026/04/27/morning-brief-asia-mixed-oil-jitters-surge-sun-pharmas-big-bet/",{"id":255,"title":256,"source":257,"logo":5,"time":141},810145,"Sun Pharma Nears $12B Organon Deal Completion; Official Announcement Expected","https://scanx.trade/stock-market-news/companies/sun-pharma-plans-13-billion-binding-offer-for-organon/38546795",{"id":259,"title":260,"source":261,"logo":17,"time":262},811113,"India’s Biggest Pharma Deal: Everything You Need To Know | What's Hot","https://www.businesstoday.in/bt-tv/market-today/video/indias-biggest-pharma-deal-everything-you-need-to-know-whats-hot-527621-2026-04-27","1H AGO",{"id":264,"title":144,"source":265,"logo":39,"time":141},810146,"https://www.linkedin.com/pulse/reliance-gets-fresh-upside-call-sun-pharmas-1175b-organon-deal-kb4hc",{"id":267,"title":268,"source":269,"logo":32,"time":193},810267,"Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal","https://www.wsj.com/business/deals/sun-pharmaceutical-to-acquire-organon-valued-at-11-75-billion-8c3e0f65",{"id":271,"title":272,"source":273,"logo":29,"time":262},811114,"Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition","https://www.forbes.com/sites/iansayson/2026/04/27/indian-billionaire-dilip-shanghvis-sun-pharma-to-buy-organon-in-deal-valued-at-118-billion/",{"id":275,"title":276,"source":277,"logo":47,"time":141},810147,"Sun Pharmaceutical zooms on inking pact to acquire all outstanding shares of Organon","https://investmentguruindia.com/newsdetail/sun-pharmaceutical-zooms-on-inking-pact-to-acquire-all-outstanding-shares-of-organon866629",{"id":279,"title":280,"source":281,"logo":41,"time":193},810268,"Sun Pharma shares jump 5% as India's largest drugmaker to buy U.S. firm Organon in $11.75 billion deal","https://www.cnbc.com/2026/04/27/indian-drugmaker-sun-pharma-to-buy-us-firm-organon-in-11point75-billion-deal.html",{"id":283,"title":284,"source":285,"logo":37,"time":171},811115,"Major outbound deals by Indian companies","https://www.dtnext.in/ampstories/web-stories/major-outbound-deals-by-indian-companies",{"id":287,"title":288,"source":289,"logo":14,"time":141},810148,"Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal","https://www.bloomberg.com/news/articles/2026-04-27/sun-pharma-to-acquire-us-listed-organon-in-12-billion-deal",{"id":291,"title":292,"source":293,"logo":52,"time":241},810269,"Organon: What The Buyout Rumors Mean For The Stock (NYSE:OGN)","https://seekingalpha.com/article/4894329-organon-what-the-buyout-rumors-mean-for-the-stock",{"id":295,"title":296,"source":297,"logo":48,"time":171},811116,"Sun Pharma's $11.75B Deal Ignites Indian Market Rebound","https://www.whalesbook.com/news/English/tech/Sun-Pharmas-dollar1175B-Deal-Ignites-Indian-Market-Rebound/69ef428b5a43f6b807c08009",{"id":299,"title":300,"source":301,"logo":55,"time":85},810149,"Sun Pharma's biggest-ever bet: Mega Organon deal, debt risk and global push","https://www.indiatoday.in/business/companies/story/sun-pharma-share-price-jumps-organon-deal-why-markets-cheered-11-75-billion-buyout-2902079-2026-04-27",{"id":303,"title":304,"source":305,"logo":11,"time":171},811117,"Sun Pharma Secures Bridge Loan for $12 Billion Organon Purchase","https://www.bloomberg.com/news/articles/2026-04-27/sun-pharma-secures-bridge-loan-for-12-billion-organon-purchase",{"id":307,"title":308,"source":309,"logo":50,"time":227},810140,"Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal","https://www.reuters.com/business/healthcare-pharmaceuticals/sun-pharma-acquire-organon-1175-bln-all-cash-deal-2026-04-27/",{"id":311,"title":312,"source":313,"logo":53,"time":314},810141,"Sun Pharma acquires Organon: growth engine or debt trap?","https://www.livemint.com/market/mark-to-market/sun-pharma-acquires-organon-sun-pharma-share-price-health-market-biosimilars-platform-pharma-ma-11777272539117.html","6H AGO",{"id":316,"title":317,"source":318,"logo":51,"time":227},810139,"Sun Pharma to buy Organon in $11.75B deal, expanding global reach (OGN:NYSE)","https://seekingalpha.com/news/4579766-sun-pharma-to-buy-organon-in-11_75b-deal-expanding-global-reach","#9a981bff","#9a981b4d",1777311049896]